Patents by Inventor Chen-Yu Zhang

Chen-Yu Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8093288
    Abstract: Genipin derivatives and pharmaceutical compositions thereof that inhibit the activity of uncoupling protein-2 (UCP2) and are useful in treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia in a mammal are disclosed.
    Type: Grant
    Filed: November 19, 2009
    Date of Patent: January 10, 2012
    Assignees: Beth Israel Deaconess Medical Center, Trustees of Boston University
    Inventors: Chen-Yu Zhang, Bradford B. Lowell, John A Porco, Jr., Ruichao Shen, Cheng T. Lin, Stefan Krauss
  • Publication number: 20100168160
    Abstract: Genipin derivatives and pharmaceutical compositions thereof that inhibit the activity of uncoupling protein-2 (UCP2) and are useful in treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia in a mammal are disclosed.
    Type: Application
    Filed: November 19, 2009
    Publication date: July 1, 2010
    Applicant: Beth Israel Deaconess Medical Center , Inc. And Trustees of Boston University
    Inventors: Chen-Yu Zhang, Bradford B. Lowell, John A. Porco, JR., Ruichao Shen, Cheng T. Lin, Stefan Krauss
  • Patent number: 7649014
    Abstract: Genipin derivatives and pharmaceutical compositions thereof that inhibit the activity of uncoupling protein-2 (UCP2) and are useful in treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia in a mammal are disclosed.
    Type: Grant
    Filed: September 29, 2005
    Date of Patent: January 19, 2010
    Assignees: Beth Israel Deaconess Medical Center, Inc., Trustees of Boston University
    Inventors: Chen-Yu Zhang, Bradford B. Lowell, John A Porco, Jr., Ruichao Shen, Cheng T. Lin, Stefan Krauss
  • Publication number: 20080009450
    Abstract: Genipin derivatives and pharmaceutical compositions thereof that inhibit the activity of uncoupling protein-2 (UCP2) and are useful in treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia in a mammal are disclosed.
    Type: Application
    Filed: September 29, 2005
    Publication date: January 10, 2008
    Inventors: Chen-Yu Zhang, Bradford Lowell, John Porco, Ruichao Shen, Cheng Lin, Stefan Krauss
  • Publication number: 20060148724
    Abstract: Genipin derivatives and pharmaceutical compositions thereof that inhibit the activity of uncoupling protein-2 (UCP2) and are useful in treating deficient first-phase insulin secretion, non-insulin dependent diabetes mellitus, and ischemia in a mammal are disclosed.
    Type: Application
    Filed: September 29, 2005
    Publication date: July 6, 2006
    Inventors: Chen-Yu Zhang, Bradford Lowell, John Porco, Ruichao Shen, Cheng Lin, Stefan Krauss
  • Patent number: 6365796
    Abstract: The present invention provides a transgenic non-human mammal which lacks a functional UCP2 gene. The UCP-2 deficient transgenic knockout mammal described herein provides a source of cells and animals useful to practice methods for the identification and/or evaluation of agents for their ability to affect signaling in cells, such as pancreatic &bgr;-cells, in which ATP serves a regulatory function. Further aspect of the invention provide a method for the identification of agents (e.g., therapeutic agents) which inhibit UCP2 activity; a method for the identification of agents which mimic UCP2 activity and a method of treating diseases or conditions associated with UCP2 function (e.g., negative regulation or uncoupling activity).
    Type: Grant
    Filed: February 16, 2000
    Date of Patent: April 2, 2002
    Assignee: Beth Israel Deaconess Medical Center
    Inventors: Bradford B. Lowell, Chen-Yu Zhang, Catherine B. Chan, Michael B. Wheeler